Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - OTHER CURRENT LIABILITIES
Other Current Liabilities SMMT - Summit Therapeutics Inc.
14.9 M
LAST VALUE
9.27%
2 YEAR CAGR
6.63%
5 YEAR CAGR
19.98%
10 YEAR CAGR